Oligonucleotide Synthesis Market: - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2030

  • Single User License $3500

Oligonucleotide Synthesis Market: - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2030

Status : June, 2021 | Biotechnology

Report Digest


Global Oligonucleotide Synthesis Market: Overview

The increasing demand for custom-made nucleotides for the required sequence through analysis, forensic applications, drug production, and genetic testing has resulted from the decreasing cost of sequencing. As a result, the global oligonucleotide synthesis market has grown through a variety of life science industries.

Several ongoing genetic testing studies make use oligonucleotide synthesis as a component. Demand for custom synthesis of various groups of oligos, such as miRNA, decoys, immunostimulatory, antisense, siRNA, and aptamers is expected to rise as investments in genetic science increase. Several large and developing oligonucleotide businesses are collaborating with pharmaceutical companies to develop their businesses. For example, GE Healthcare Dharmacon Inc. and CordenPharma International penned a strategic partnership in June 2017 to create an end-to-end oligonucleotide-based approach of drug discovery.

The global oligonucleotide synthesis market&rd research makes an inclusion of main market segments such as end use, type, product, application and regional markets. It also examines the global oligonucleotide synthesis market's present competitiveness over the projected period of 2020 to 2030.

Global Oligonucleotide Synthesis Market: Key Trends

A large number of oligos are currently being tested in late-stage clinical trials for several conditions, such as ocular disorders, cancer, muscle dystrophies, and cardiovascular disease amongst many other conditions. The industry is expected to be propelled by the upcoming regulatory clearance of multiple oligonucleotide-based therapies.

Direct sale and distribution to dealers in certain countries are two marketing strategies used in this region. The industry is expected to benefit from the ongoing development of the genomics and gene editing industries, as advances in genetic tools would make oligonucleotide synthesis easier. All these factors are likely to work in favor of the expansion of the global oligonucleotide synthesis market in the years to come.

Authorities in a number of countries have invested substantially in programmes relating to genomics and synthetic biology in the last few years. Such government investments have aided the advancement of emerging technology significantly. Oligonucleotides are an important part of these innovations, and increased spending and advancement in these fields is likely to accelerate growth of the global oligonucleotide synthesis market over the analysis tenure, from 2020 to 2030.

Global Oligonucleotide Synthesis Market: Competitive Assessment

High-end business growth techniques such as developments,extension, alliance, and cooperation are also being used by prominent companies in the global oligonucleotide synthesis market. The companies also conduct research and development activities in order to provide consumers with more and more specialized goods. To keep up with the increasing demand for the product from customers all over the world, a few of the market players are also introducing new and advanced models.

Some of the well-known players in the global oligonucleotide synthesis market are listed below

  • Integrated DNA Technologies, Inc
  • Thermo Fisher Scientific, Inc.
  • GE Healthcare Dharmacon Inc
  • LGC Biosearch Technologies
  • Agilent Technologies
  • Kaneka Eurogentec S.A  

Global Oligonucleotide Synthesis Market: Regional Assessment

Because of the presence of well - established companies and inventors in the US, product penetration has increased. As a result, North America has come up as one of the leading regions in the global oligonucleotide synthesis market and the trend is expected to continue over the forecast period, from 2020 to 2030. In addition to that, North America's good position in drug discovery, oncology,genomics, proteomics, and medical imaging has helped it retain its significant market share.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?